Korea Investment CORP Trims Stock Holdings in Intuitive Surgical, Inc. $ISRG

Korea Investment CORP reduced its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.8% in the third quarter, according to its most recent filing with the SEC. The fund owned 293,189 shares of the medical equipment provider’s stock after selling 8,390 shares during the period. Korea Investment CORP owned about 0.08% of Intuitive Surgical worth $131,123,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of ISRG. Tobam boosted its position in Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 40 shares during the period. Kilter Group LLC bought a new position in Intuitive Surgical in the 2nd quarter worth about $27,000. Greykasell Wealth Strategies Inc. bought a new position in Intuitive Surgical in the 3rd quarter worth about $27,000. Caitlin John LLC purchased a new position in shares of Intuitive Surgical during the third quarter worth approximately $30,000. Finally, Guerra Advisors Inc purchased a new position in shares of Intuitive Surgical during the third quarter worth approximately $37,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, SVP Mark Brosius sold 4,500 shares of the company’s stock in a transaction on Friday, December 12th. The stock was sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the completion of the sale, the senior vice president directly owned 907 shares in the company, valued at $496,455.52. This represents a 83.23% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Gary S. Guthart sold 24,500 shares of the stock in a transaction dated Tuesday, January 27th. The shares were sold at an average price of $530.10, for a total transaction of $12,987,450.00. Following the sale, the director directly owned 3,694 shares of the company’s stock, valued at approximately $1,958,189.40. The trade was a 86.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 37,261 shares of company stock valued at $19,690,721. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $490.16 on Friday. The company has a market cap of $174.07 billion, a PE ratio of 62.12, a P/E/G ratio of 3.78 and a beta of 1.66. The firm’s 50 day moving average price is $521.64 and its 200-day moving average price is $512.28. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. Intuitive Surgical’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.21 earnings per share. On average, analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts recently issued reports on ISRG shares. TD Cowen upgraded Intuitive Surgical to a “strong-buy” rating in a report on Tuesday, January 27th. Raymond James Financial raised their price objective on Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a report on Friday, January 23rd. Barclays set a $712.00 target price on Intuitive Surgical and gave the company an “overweight” rating in a research report on Monday, January 26th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday, December 29th. Finally, Robert W. Baird dropped their price target on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a research report on Friday, January 23rd. Two research analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $615.86.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.